Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Alzheimer'S Research & Therapy
|
July 18, 2014
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
Lars Lannfelt, Christer Möller, Hans Basun, et al.
Neuro-Degenerative Diseases
|
August 16, 2006
Clinical and molecular aspects of frontotemporal dementia
Susanne Froelich-Fabre, Lena Skoglund, Jovanka Ostojic, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2012
Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials
Bob Olsson, Clas Malmeström, Hans Basun, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2009
Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study
Johan Sundelöf, Lena Kilander, Johanna Helmersson, et al.
Journal of Alzheimer'S Disease : JAD
|
September 1, 2012
Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease
Kina Höglund, Anna Bogstedt, Susanne Fabre, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2009
Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study
Johan Sundelöf, Lena Kilander, Johanna Helmersson, et al.
Molecular and Cellular Neurosciences
|
June 6, 2021
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
Malin Johannesson, Charlotte Sahlin, Linda Söderberg, et al.
Brain Pathology (Zurich, Switzerland)
|
May 31, 2017
Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury
Sami Abu Hamdeh, Erik Rollman Waara, Christer Möller, et al.
Journal of Alzheimer'S Disease : JAD
|
April 9, 2013
Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study
Gerd Faxén-Irving, Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, et al.
Neurogenetics
|
October 16, 2008
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation
Lena Skoglund, RoseMarie Brundin, Tommie Olofsson, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Alzheimer'S Research & Therapy
|
July 18, 2014
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
Lars Lannfelt, Christer Möller, Hans Basun, et al.
Neuro-Degenerative Diseases
|
August 16, 2006
Clinical and molecular aspects of frontotemporal dementia
Susanne Froelich-Fabre, Lena Skoglund, Jovanka Ostojic, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2012
Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials
Bob Olsson, Clas Malmeström, Hans Basun, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2009
Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study
Johan Sundelöf, Lena Kilander, Johanna Helmersson, et al.
Journal of Alzheimer'S Disease : JAD
|
September 1, 2012
Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease
Kina Höglund, Anna Bogstedt, Susanne Fabre, et al.
Journal of Alzheimer'S Disease : JAD
|
June 23, 2009
Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study
Johan Sundelöf, Lena Kilander, Johanna Helmersson, et al.
Molecular and Cellular Neurosciences
|
June 6, 2021
Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease
Malin Johannesson, Charlotte Sahlin, Linda Söderberg, et al.
Brain Pathology (Zurich, Switzerland)
|
May 31, 2017
Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury
Sami Abu Hamdeh, Erik Rollman Waara, Christer Möller, et al.
Journal of Alzheimer'S Disease : JAD
|
April 9, 2013
Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study
Gerd Faxén-Irving, Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, et al.
Neurogenetics
|
October 16, 2008
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation
Lena Skoglund, RoseMarie Brundin, Tommie Olofsson, et al.
Page
of 6